Eledon Pharmaceuticals, Inc. ELDN

Set alert

Price alert · ELDN

All alert types
2.77 USD -0.27 -8.88%

At close · Oct 30

2.93 +0.16 +5.68%

After hours · Oct 30, 7:57 PM ET

Bid
2.77 × 2
Ask
2.78 × 2
2.75 Day range 3.04
1.39 52-week range 4.36
YTD
+83.44%
1 year
-36.32%
Open
3.01
Prev close
3.04
Mkt cap
225.09M
Vol
1.27M
Avg vol
925.59K
EPS
-0.90
P/E
0.00
Div yield
0.00%
More statistics
Low
2.75
High
3.04
Forward P/E
-3.49
Beta
0.00
Short ratio
0.75
Inst. own
42.88%
Dividend
0.00
Ex-div date
50-d avg
4.12
200-d avg
2.88
1y target
12.50

5D chart

Chart tools
Interval

Signals (60)
NameTimeAgo
MACD: Buy SignalOct 29, 3:20 PM2 days ago
SMA: BullishOct 29, 2:50 PM2 days ago
RSI: OversoldOct 29, 2:40 PM2 days ago
SMA: BearishOct 29, 1:55 PM2 days ago
RSI: OverboughtOct 29, 1:25 PM2 days ago
RSI: OverboughtOct 29, 1:00 PM2 days ago
RSI: OverboughtOct 29, 12:40 PM2 days ago
SMA: BullishOct 29, 12:30 PM2 days ago
SMA: BearishOct 29, 12:25 PM2 days ago
MACD: Sell SignalOct 29, 12:10 PM2 days ago
RSI: OverboughtOct 29, 11:50 AM2 days ago
MACD: Buy SignalOct 29, 11:10 AM3 days ago
RSI: OverboughtOct 29, 11:10 AM3 days ago
MACD: Sell SignalOct 29, 11:05 AM3 days ago
RSI: OverboughtOct 29, 10:55 AM3 days ago
RSI: OverboughtOct 29, 10:30 AM3 days ago
RSI: OverboughtOct 29, 10:10 AM3 days ago
RSI: OverboughtOct 29, 9:45 AM3 days ago
RSI: OverboughtOct 29, 9:35 AM3 days ago
RSI: OverboughtOct 28, 2:45 PM3 days ago
MACD: Buy SignalOct 28, 2:30 PM3 days ago
RSI: OverboughtOct 28, 1:10 PM3 days ago
MACD: Sell SignalOct 28, 1:05 PM3 days ago
MACD: Buy SignalOct 28, 12:35 PM3 days ago
RSI: OverboughtOct 28, 12:35 PM3 days ago
MACD: Sell SignalOct 28, 12:05 PM3 days ago
RSI: OverboughtOct 28, 11:50 AM3 days ago
MACD: Buy SignalOct 28, 11:40 AM3 days ago
MACD: Sell SignalOct 28, 11:35 AM3 days ago
MACD: Buy SignalOct 28, 11:25 AM4 days ago
RSI: OverboughtOct 28, 11:20 AM4 days ago
MACD: Sell SignalOct 28, 10:55 AM4 days ago
RSI: OverboughtOct 28, 10:25 AM4 days ago
MACD: Buy SignalOct 28, 9:50 AM4 days ago
MACD: Sell SignalOct 28, 9:30 AM4 days ago
MACD: Buy SignalOct 27, 2:45 PM4 days ago
RSI: OverboughtOct 27, 2:45 PM4 days ago
MACD: Sell SignalOct 27, 12:05 PM4 days ago
RSI: OverboughtOct 27, 11:35 AM4 days ago
RSI: OverboughtOct 27, 10:40 AM5 days ago
SMA: BullishOct 27, 9:30 AM5 days ago
SMA: BullishOct 27, 9:30 AM5 days ago
MACD: Buy SignalOct 27, 9:30 AM5 days ago
RSI: OversoldOct 26, 3:00 PM5 days ago
MACD: Sell SignalOct 26, 2:45 PM5 days ago
SMA: BearishOct 26, 12:50 PM5 days ago
SMA: BearishOct 26, 12:50 PM5 days ago
SMA: BullishOct 26, 12:45 PM5 days ago
SMA: BullishOct 26, 12:30 PM5 days ago
MACD: Buy SignalOct 26, 12:20 PM5 days ago
SMA: BearishOct 26, 11:25 AM6 days ago
SMA: BullishOct 26, 11:15 AM6 days ago
RSI: OversoldOct 26, 11:00 AM6 days ago
MACD: Sell SignalOct 26, 10:05 AM6 days ago
RSI: OverboughtOct 23, 3:40 PM1 week ago
MACD: Buy SignalOct 23, 3:05 PM1 week ago
MACD: Sell SignalOct 23, 1:20 PM1 week ago
MACD: Buy SignalOct 23, 12:40 PM1 week ago
MACD: Sell SignalOct 23, 12:25 PM1 week ago
SMA: BullishOct 23, 10:50 AM1 week ago

Financial health

Altman Z-Score

-4.09 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -2.7×
FY 2016: -0.4×FY 2017: -1.8×FY 2018: -1.0×FY 2019: -0.4×FY 2020: -0.9×FY 2021: -1.9×FY 2022: -0.4×FY 2023: -0.4×FY 2024: -5.5×FY 2025: -2.7×
FY 2016 5y median -1.9× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.5×
FY 2016: 24.5×FY 2017: 17.6×FY 2018: 17.9×FY 2019: 13.0×FY 2020: 1.2×FY 2021: 0.4×FY 2022: 0.4×FY 2023: 6.1×FY 2024: 1.7×FY 2025: 1.5×
FY 2016 5y median 1.5× FY 2025
P/FCF -2.0×
FY 2016: -18.0×FY 2017: -22.9×FY 2018: -21.8×FY 2019: -8.9×FY 2020: -15.3×FY 2021: -2.3×FY 2022: -1.1×FY 2023: -1.1×FY 2024: -4.2×FY 2025: -2.0×
FY 2016 5y median -2.0× FY 2025
EV/EBITDA -2.2×
FY 2016: -92.6×FY 2017: -24.8×FY 2018: -17.5×FY 2019: -7.2×FY 2020: -7.5×FY 2021: 0.5×FY 2022: 0.6×FY 2023: -0.3×FY 2024: -5.1×FY 2025: -2.2×
FY 2016 5y median -0.3× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -50.4%
FY 2016: -5.6%FY 2017: -4.4%FY 2018: -4.6%FY 2019: -11.2%FY 2020: -6.5%FY 2021: -44.2%FY 2022: -87.3%FY 2023: -89.2%FY 2024: -23.6%FY 2025: -50.4%
FY 2016 5y median -50.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -56.3%
FY 2016: -141.3%FY 2017: -67.4%FY 2018: -97.1%FY 2019: -169.2%FY 2020: -12.0%FY 2021: -21.0%FY 2022: -104.5%FY 2023: -1616.8%FY 2024: -30.6%FY 2025: -56.3%
FY 2016 5y median -56.3% FY 2025
ROIC -55.1%
FY 2016: -125.4%FY 2017: -67.5%FY 2018: -97.0%FY 2019: -144.9%FY 2020: -9.3%FY 2021: -20.7%FY 2022: -102.0%FY 2023: -50.3%FY 2024: -42.5%FY 2025: -55.1%
FY 2016 5y median -50.3% FY 2025
ROA -27.0%
FY 2016: -127.5%FY 2017: -62.8%FY 2018: -82.6%FY 2019: -146.5%FY 2020: -11.6%FY 2021: -20.2%FY 2022: -94.8%FY 2023: -130.8%FY 2024: -20.4%FY 2025: -27.0%
FY 2016 5y median -27.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -18.0%
FY 2016: 15.8%FY 2017: 65.6%FY 2018: -7.2%FY 2019: -0.9%FY 2020: -30.2%FY 2021: -99.7%FY 2022: -139.9%FY 2023: 51.4%FY 2024: -64.1%FY 2025: -18.0%
FY 2016 FY 2025
EPS (diluted) 25.3%
FY 2016: -22.4%FY 2017: 89.6%FY 2018: 32.1%FY 2019: 13.1%FY 2020: 29.7%FY 2021: 86.4%FY 2022: -164.4%FY 2023: 23.2%FY 2024: 84.1%FY 2025: 25.3%
FY 2016 FY 2025
Free Cash Flow -31.9%
FY 2016: 12.6%FY 2017: 59.1%FY 2018: 20.4%FY 2019: -16.5%FY 2020: -9.8%FY 2021: -90.1%FY 2022: 1.7%FY 2023: -39.1%FY 2024: -19.6%FY 2025: -31.9%
FY 2016 FY 2025

Financial Health

Current Ratio 7.4×
FY 2016: 10.5×FY 2017: 13.2×FY 2018: 5.6×FY 2019: 7.5×FY 2020: 46.6×FY 2021: 20.1×FY 2022: 9.2×FY 2023: 14.4×FY 2024: 12.4×FY 2025: 7.4×
FY 2016 5y median 12.4× FY 2025
Quick Ratio 7.4×
FY 2016: 10.5×FY 2017: 13.2×FY 2018: 5.6×FY 2019: 6.9×FY 2020: 46.6×FY 2021: 20.1×FY 2022: 9.2×FY 2023: 14.4×FY 2024: 12.4×FY 2025: 7.4×
FY 2016 5y median 12.4× FY 2025
Debt / Equity 0.0×
FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 2.9×FY 2017: 1.3×FY 2018: 0.9×FY 2019: 0.5×FY 2020: 7.1×FY 2021: 2.3×FY 2022: 1.4×FY 2023: 0.0×FY 2024: 0.6×FY 2025: 0.5×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -1.9×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -0.1%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31